Start a conversation Capability 01
Know what you are buying. Know its path to approval.
Independent assessment of a licensing, acquisition, investment, or partnership opportunity—translated into a clear executive recommendation.
The problem
Promising science can conceal clinical, regulatory, statistical, safety, or execution risks that materially change asset value. Decision-makers need more than a data-room summary; they need an integrated view of approvability, differentiation, and probability of success.
The HEOS solution
HEOS brings senior physician and pharmaceutical executives together to evaluate the evidence, interrogate the development plan, test the regulatory path, and identify the conditions required for a sound investment decision.
How we do it
Senior experts work from assessment through execution, with clear decisions, accountable actions, and measurable outcomes.
Review the complete data room, scientific rationale, efficacy, safety, trial design, endpoints, statistics, and prior regulatory interactions.
Surface development gaps, additional studies, optimal indications, competitive risks, and value-creating opportunities.
Deliver an executive recommendation: go, go with conditions, renegotiate, additional diligence, or no-go.
What you get
How success is measured
The finish line
Experienced expertise. Better decisions.
Tell us what you are evaluating, building, or preparing to execute. We will help you define the right engagement.